Cipro Levaquin Lawsuit Update

The Cipro Levaquin Lawsuit is a case in point against the makers and distributors of Flagyl, the generic version of Cipro. The manufacturer of this medication, Dr. Arthur J. Libis, is accused of knowingly selling a dangerous and ineffective medicine while overcharging customers for the drug. The suit was brought by Arthur Levaquin, a dentist from Houston, Texas. According to the complaint, he purchased three boxes of Cipro on behalf of his dental patients, thinking that he would treat their dental problems with the same medicine as the original. Instead, he discovered that the generic medication had many unpleasant side effects.

These unpleasant effects include allergic reactions, including redness, swelling, itching, burning, stomach pain, dizziness, diarrhea, and respiratory depression.

It was not until several months after taking Cipro online did Levaquin begin to experience these symptoms. It seems that while he was taking the drug, Arthur was also taking higher doses of aspirin, which aggravates the effect of the otic suspension. In addition, he continued to take the aspirin for up to seven months before even noticing any change. It is important to remember that while he was aware of the dangers of taking Cipro online, he did not mention these potential side effects to the salesperson, as required by law.

After examining the medical records of one of his patients, the dentist conducted his investigation. He discovered that while taking Zanaflex Cipro he had severe allergic reactions to the otic suspension. The patient’s blood work was sent to the hospital for analysis, and the results showed that he was allergic to the otic. Subsequently, he was diagnosed with esophageal cancer. Levaquin’s attorney, Robert Zircon, has filed a complaint against Levaquin and Cipro International, stating that Levaquin was given the medication “illegally” in violation of Food and Drug Administration (FDA) policy. According to the FDA policy, drugs are only given to people with “known” conditions and are never meant for “off-label” usage.

Zircon further stated that Levaquin was sold in doctor’s offices across the country without prescription by pharmacies that did not require a prescription to sell the medication.

He further stated that Levaquin was sold in stores without a prescription in New York, Ohio, California, Maryland, Wisconsin, Illinois, Florida, New Jersey, and Washington. This is a direct violation of FDCPA regulations, according to Zircon. The FDA has referred to Levaquin as a controlled substance, stating, “It poses a substantial risk of harm when used [and] not properly prescribed.” Zircon added that Levaquin “was sold as an over-the-counter medicine in various locations, including on websites that sell dietary supplements and health articles.”

Levaquin is currently scheduled for trial on a date in June of 2021. Zircon claims that the company has evidence that Levaquin was being sold illegally under its brand name and that it was missed in this way in several states. He additionally stated that he would file additional complaints against Cipro International, the company that manufactures the prescription drug, as well as independent distributors who distributed Cipro without a prescription.

For the time being, there seems to be a difference of opinion regarding whether or not Levaquin can be taken Cipro without a prescription.

While there was a case filed against Cipro by a former distributor of the drug, there appears to be little litigation surrounding the legality of taking the medication under any circumstance. The only true issue is whether or not the flag was sold without a prescription by distributors. It’s important to remember that this is a class action suit, and is not a simple dispute between individual consumers. Whether or not you have to take Cipro Flagyl with a doctor’s prescription remains a question that will need to be addressed through the court system.